Paper Details

  1. Home
  2. Paper Details

Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendations.

Author: BolandMelinde R S, GoossensLucas M A, KocksJanwillem W H, PostmaMaarten J, Rutten-van MölkenMaureen P M H, van BovenJob F M, van der SchansSimon

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Chronic obstructive pulmonary disease (COPD) is a common lung disease with significant impact on health and economics. While the cost-effectiveness of COPD medications has been studied, these studies haven't fully considered the order in which medications are used and the specific stages of the disease they are used for in real-world settings.
Paper Details　
Original Abstract of the Article :
Worldwide, chronic obstructive pulmonary disease (COPD) is a highly prevalent chronic lung disease with considerable clinical and socioeconomic impact. Pharmacologic maintenance drugs (such as bronchodilators and inhaled corticosteroids) play an important role in the treatment of COPD. The cost effe...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209411/

データ提供：米国国立医学図書館（NLM）

Evaluating the Cost-Effectiveness of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease

This study examines the cost-effectiveness of pharmacologic maintenance treatments for chronic obstructive pulmonary disease (COPD), a prevalent lung disease with substantial clinical and socioeconomic impact. The authors conducted a systematic review and quality appraisal of cost-effectiveness analyses, highlighting the need for a more nuanced approach to evaluating the cost-effectiveness of COPD treatments, taking into account treatment sequence and the specific stage of disease. The study emphasizes the importance of robust methodology and relevant data to inform decision-making regarding COPD management.

Optimizing COPD Treatment Strategies: A Focus on Cost-Effectiveness

The research highlights the importance of considering cost-effectiveness in evaluating treatment options for COPD. The study's findings underscore the need for research that takes into account the dynamic nature of COPD and the impact of treatment sequence on outcomes and costs. This information can help inform the development of evidence-based guidelines for COPD management.

Navigating the Costs and Benefits of COPD Treatment

COPD is a chronic condition that requires long-term management, posing significant challenges for patients, caregivers, and healthcare systems. This study emphasizes the need for a balanced approach to COPD management, weighing the benefits of pharmacologic treatments against their associated costs. The findings underscore the importance of continued research to identify cost-effective treatment strategies that optimize patient outcomes and minimize the economic burden of this chronic disease.

Dr. Camel's Conclusion

This research is like a camel caravan traversing a vast and unforgiving desert, seeking the most cost-effective path to manage COPD. The study highlights the importance of considering both the benefits and costs of treatment, emphasizing the need for a comprehensive and nuanced approach to this complex condition. The journey to find optimal treatment strategies for COPD is as challenging as a desert trek, requiring careful planning, resourcefulness, and a commitment to improving patient lives.

Date :
  1. Date Completed 2017-10-30
  2. Date Revised 2019-07-25
Further Info :

Pubmed ID

27592021

DOI: Digital Object Identifier

PMC5209411

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.